HERPES ZOSTER (HZ)
Clinical trials for HERPES ZOSTER (HZ) explained in plain language.
Never miss a new study
Get alerted when new HERPES ZOSTER (HZ) trials appear
Sign up with your email to follow new studies for HERPES ZOSTER (HZ), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New shingles vaccine shows promise in Head-to-Head trial
⭐️ VACCINE ⭐️ OngoingThis study tests a new shingles vaccine called JCXH-105 in healthy adults aged 50 and older. About 467 participants will receive either JCXH-105 or the current vaccine Shingrix to compare safety and immune response. The goal is to see if the new vaccine can prevent shingles as we…
Matched conditions: HERPES ZOSTER (HZ)
Phase: PHASE2 • Sponsor: Immorna Biotherapeutics, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 06:46 UTC
-
New shingles vaccine shows promise in Mid-Stage trial
⭐️ VACCINE ⭐️ OngoingThis study tests a new vaccine called LYB004 to see if it can safely protect adults aged 40 and older from shingles, a painful rash caused by the chickenpox virus. About 840 participants in China will receive the vaccine and be monitored for side effects and immune response. The …
Matched conditions: HERPES ZOSTER (HZ)
Phase: PHASE2 • Sponsor: Guangzhou Patronus Biotech Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated May 15, 2026 11:53 UTC